1260825-29-3 Usage
Description
1-(3-chloro-2-fluorophenyl)cyclobutane-1-carbonitrile is a chemical compound belonging to the class of organic compounds known as benzonitriles. It features a molecular formula of C11H8ClFN and is characterized by a cyclobutane ring with a carbonitrile group attached. 1-(3-chloro-2-fluorophenyl)cyclobutane-1-carbonitrile also contains a phenyl ring with a chlorine and a fluorine atom, contributing to its potential biological activities.
Uses
Used in Pharmaceutical Industry:
1-(3-chloro-2-fluorophenyl)cyclobutane-1-carbonitrile is used as a building block for the synthesis of complex organic compounds with potential medicinal properties. Its cyclobutane and carbonitrile groups are known for their biological activities, making it a valuable component in the development of new drugs.
Used in Agrochemical Industry:
Similarly, in the agrochemical industry, 1-(3-chloro-2-fluorophenyl)cyclobutane-1-carbonitrile serves as a building block for the synthesis of organic compounds with potential applications in agriculture. Its unique structure and functional groups can be utilized to create compounds that may have pesticidal, herbicidal, or other agricultural benefits.
Check Digit Verification of cas no
The CAS Registry Mumber 1260825-29-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,6,0,8,2 and 5 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1260825-29:
(9*1)+(8*2)+(7*6)+(6*0)+(5*8)+(4*2)+(3*5)+(2*2)+(1*9)=143
143 % 10 = 3
So 1260825-29-3 is a valid CAS Registry Number.
1260825-29-3Relevant articles and documents
Oxadiazole Amine Derivative Compounds as Histone Deacetylase 6 Inhibitor, and the Pharmaceutical Composition Comprising the same
-
, (2017/07/18)
The present invention relates to a novel compound having an activity of inhibiting histone deacetylase 6 (HDAC6), an optical isomer thereof or a pharmaceutically acceptable salt thereof, a use thereof for preparation of a drug for treatment, a pharmaceutical composition comprising the same, a treatment method using the composition, and a method for preparing the same. The novel compound, an optical isomer thereof or a pharmaceutically acceptable salt thereof according to the present invention has an activity of inhibiting histone deacetylase 6 (HDAC6), and is effective for preventing or treating HDAC6-related diseases, including infectious diseases; neoplasm; endocrine, nutritional and metabolic diseases; mental and behavior disorders; nerve disorders; eye and adnexa diseases; cardiovascular diseases; respiratory diseases; digestive organ diseases; skin and subcutaneous tissue diseases; musculoskeletal and connective tissue diseases; or congenital malformation, deformation and chromosomal abnormality.COPYRIGHT KIPO 2017
